Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Short-term Investments (2020 - 2025)

Historic Short-term Investments for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Q3 2025 value amounting to $93.5 million.

  • Mirum Pharmaceuticals' Short-term Investments rose 5213.58% to $93.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $93.5 million, marking a year-over-year increase of 5213.58%. This contributed to the annual value of $57.8 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Mirum Pharmaceuticals' Short-term Investments is $93.5 million, which was up 5213.58% from $76.4 million recorded in Q2 2025.
  • Mirum Pharmaceuticals' 5-year Short-term Investments high stood at $149.6 million for Q3 2022, and its period low was $3.0 million during Q3 2023.
  • Its 5-year average for Short-term Investments is $86.4 million, with a median of $82.7 million in 2023.
  • In the last 5 years, Mirum Pharmaceuticals' Short-term Investments crashed by 9801.39% in 2023 and then soared by 196920.23% in 2024.
  • Quarter analysis of 5 years shows Mirum Pharmaceuticals' Short-term Investments stood at $125.2 million in 2021, then decreased by 1.19% to $123.7 million in 2022, then crashed by 97.6% to $3.0 million in 2023, then skyrocketed by 1845.88% to $57.8 million in 2024, then skyrocketed by 61.78% to $93.5 million in 2025.
  • Its Short-term Investments stands at $93.5 million for Q3 2025, versus $76.4 million for Q2 2025 and $65.9 million for Q1 2025.